All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Malignant disease as an incidental finding at 18F-FDG-PET/CT scanning in patients with granulomatous lung disease

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33156742" target="_blank" >RIV/61989592:15110/15:33156742 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1097/MNM.0000000000000274" target="_blank" >http://dx.doi.org/10.1097/MNM.0000000000000274</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1097/MNM.0000000000000274" target="_blank" >10.1097/MNM.0000000000000274</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Malignant disease as an incidental finding at 18F-FDG-PET/CT scanning in patients with granulomatous lung disease

  • Original language description

    PURPOSE: Fluorine-18 fluorodeoxyglucose (18F-FDG)-PET/computed tomography (CT) is used for assessment of the extent and activity of disease in patients with inflammatory granulomatous lung disease, in particular sarcoidosis and tuberculosis. The aim of this retrospective analysis was to assess the value of 18F-FDG-PET/CT in the identification of previously unknown malignant disease during routine investigation of granulomatous lung disease. MATERIALS AND METHODS: From July 2008 to December 2013, a totalof 122 patients with tuberculosis (76 male and 46 female patients; age range 19.6-88.6 years, mean 52.8+-16.6 years) and 85 patients with sarcoidosis (46 male and 39 female patients; age range 17.8-76.5 years, mean 48.6+-13.8 years) underwent 18F-FDG-PET/CT. Reports were generated in consensus by both a nuclear medicine physician and a radiologist. Possibly malignant findings underwent biopsies and/or follow-up. Quantitative parameters (maximum standardized uptake value) were pooled and

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Nuclear Medicine Communications

  • ISSN

    0143-3636

  • e-ISSN

  • Volume of the periodical

    36

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    430-437

  • UT code for WoS article

  • EID of the result in the Scopus database